Rigel Pharmaceuticals (RIGL) Other Non-Current Assets (2010 - 2026)
Rigel Pharmaceuticals' quarterly Other Non-Current Assets came in at $2.4 million in Q1 2026, up 55.47% year-on-year from $1.5 million in Q1 2025, and up 23.53% quarter-over-quarter from $1.9 million in Q4 2025.
Rigel Pharmaceuticals has reported Other Non-Current Assets for 17 years, with the latest figure at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 55.47% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 55.47% YoY), and the FY2025 full-year result was $1.9 million, up 24.95% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.4 million, up from $1.9 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $5.0 million in Q3 2023, with the low at $403000.0 in Q2 2022.
- Average Other Non-Current Assets over 5 years is $2.2 million, with a median of $1.5 million recorded in 2024.
- Year-over-year, Other Non-Current Assets soared 923.97% in 2023 and sank 75.49% in 2025.
- Tracing RIGL's Other Non-Current Assets over 5 years: stood at $640000.0 in 2022, then soared by 377.34% to $3.1 million in 2023, then slumped by 50.02% to $1.5 million in 2024, then gained by 24.95% to $1.9 million in 2025, then increased by 23.53% to $2.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $2.4 million (Q1 2026), $1.9 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 2.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.36 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 4.74 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 3.06 Mn |
| Sep 30, 2023 | 4.96 Mn |
| Jun 30, 2023 | 541,000.00 |
| Mar 31, 2023 | 542,000.00 |
| Dec 31, 2022 | 640,000.00 |
| Sep 30, 2022 | 484,000.00 |
| Jun 30, 2022 | 403,000.00 |
| Mar 31, 2022 | 464,000.00 |
| Dec 31, 2021 | 974,000.00 |
| Sep 30, 2021 | 935,000.00 |
| Jun 30, 2021 | 840,000.00 |
| Mar 31, 2021 | 818,000.00 |
| Dec 31, 2020 | 824,000.00 |
| Sep 30, 2020 | 820,000.00 |
| Jun 30, 2020 | 653,000.00 |
| Mar 31, 2020 | 661,000.00 |
| Dec 31, 2019 | 696,000.00 |
| Sep 30, 2019 | 695,000.00 |
| Jun 30, 2019 | 713,000.00 |
| Mar 31, 2019 | 729,000.00 |
| Dec 31, 2018 | 735,000.00 |
| Sep 30, 2018 | 652,000.00 |
| Jun 30, 2018 | 678,000.00 |
| Mar 31, 2018 | 754,000.00 |
| Dec 31, 2017 | 803,000.00 |
| Sep 30, 2017 | 770,000.00 |
| Jun 30, 2017 | 704,000.00 |
| Mar 31, 2017 | 730,000.00 |
| Dec 31, 2016 | 764,000.00 |
| Sep 30, 2016 | 800,000.00 |
| Jun 30, 2016 | 842,000.00 |
| Mar 31, 2016 | 1.06 Mn |
| Dec 31, 2015 | 1.11 Mn |
| Sep 30, 2015 | 1.17 Mn |
| Jun 30, 2015 | 1.02 Mn |
| Mar 31, 2015 | 1.06 Mn |
| Dec 31, 2014 | 1.09 Mn |
| Sep 30, 2014 | 1.41 Mn |
| Jun 30, 2014 | 1.46 Mn |
| Mar 31, 2014 | 1.48 Mn |
| Dec 31, 2013 | 1.53 Mn |
| Sep 30, 2013 | 1.59 Mn |
| Jun 30, 2013 | 1.64 Mn |
| Mar 31, 2013 | 1.70 Mn |
| Dec 31, 2012 | 1.76 Mn |
| Sep 30, 2012 | 1.83 Mn |
| Jun 30, 2012 | 1.88 Mn |
| Mar 31, 2012 | 1.93 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Sep 30, 2011 | 2.05 Mn |
| Jun 30, 2011 | 2.13 Mn |
| Dec 31, 2010 | 2.24 Mn |